Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
0.5860
-0.0035 (-0.59%)
At close: Jan 16, 2026
BCLI Market Cap
BCLI has a market cap or net worth of $6.47 million as of January 20, 2026. Its market cap has decreased by -50.05% in one year.
Market Cap
6.47M
Enterprise Value
6.89M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.59
Market Cap Chart
Since May 28, 2003, BCLI's market cap has increased from 454.50K to 6.47M, an increase of 1,322.76%. That is a compound annual growth rate of 12.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 6.47M | 5.97% |
| Dec 31, 2025 | 6.10M | -52.87% |
| Dec 31, 2024 | 12.95M | -3.18% |
| Dec 29, 2023 | 13.37M | -77.69% |
| Dec 30, 2022 | 59.93M | -58.70% |
| Dec 31, 2021 | 145.11M | 1.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |